Tag: pharmaceutical grade cannabis

December 5, 2019

FSD Pharma to Present at 12th Annual LD Micro Main Event Investor Conference on December 11

FSD Pharma announces that Edward Brennan, MD, President, BioSciences Division, will present at the 12th Annual LD Micro Main Event Investor...
December 4, 2019

Pure Global Announces Closing of First Tranche of Private Placement

Pure Global Cannabis Inc. is pleased to announce that it has completed its previously announced draw-down on the first tranche...
December 2, 2019

FSD Pharma Reports Third Quarter 2019 Financial Results

FSD Pharma Inc. (CSE:HUGE, OTCQB:FSDDF, FRA:0K9) reported financial and operational results for the three and nine months ended September 30,...
November 28, 2019

Pure Global Announces Private Placement

Pure Global is pleased to announce that it proposes to draw-down on the first tranche of its equity financing facility...
November 19, 2019

Pure Global Reiterates Manufacturing Approvals and Announces Financing

Production at Brampton Manufacturing Hub to commence immediately, Pure Global announces financing agreement with Alumina Partners
November 18, 2019

Pure Global Receives Health Canada Approvals for 12 Cultivation, Processing, and Extraction Rooms

Pure Global is pleased to announce that it has received approvals from Health Canada to amend its existing license to...
November 4, 2019

FSD Pharma Second Tranche of Private Placement Closes, Total of $4.59 Million Raised at $20.10 To Date, Extends Offering

FSD Pharma Inc. announces that it has closed a second tranche of its previously announced private placement.